Bioorganic and Medicinal Chemistry Letters p. 307 - 310 (1996)
Update date:2022-08-05
Topics:
Rivero
Kevin
Kivlighn
Zingaro
Chang
Greenlee
Simple modifications made to our potent angiotensin II AT1 selective clinical candidate MK-996 provided a compound with balanced binding affinity to both the AT1 and the AT2 receptor subtype. This compound, L-162,389 is or
View MoreTianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Suzhou Credit International Trading Co., Ltd
Contact:+86-512-65398039
Address:Qingdeng, Hightech. District, Suzhou
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Contact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Suzhou Sinosun Imp.&Exp. Corporation
website:http://www.szsinosun.com
Contact:+86-512-63488895,63488616
Address:No.758 East Jiangling Road Wujiang Economic & Technological Developmenty Zone Jiangsu China
Doi:10.1016/j.tet.2016.01.021
(2016)Doi:10.1021/ol025627w
(2002)Doi:10.1016/S0040-4039(97)01728-0
(1997)Doi:10.1021/om400452q
(2013)Doi:10.1021/jo00058a005
(1993)Doi:10.1107/S010827019600491X
(1996)
